Navigation Links
FDA Approves First-of-its-Kind Drug to Treat Rare Blood Disorder

The U.S. Food and Drug Administration (FDA) today approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria// (PNH), a rare type of blood disorder that can lead to disability and premature death. Soliris is classified as an Orphan Drug and is a new molecular entity containing an ingredient not previously marketed in the United States.

"This product is important in that it offers a treatment other than blood transfusion that may help this small population of patients who are often very ill," said Steven Galson, M.D., M.P.H., director, Center for Drug Evaluation and Research, FDA. "This approval is one of multiple examples of how the orphan products program can benefit the public health with urgently needed products that would otherwise not be commercially available."

PNH, which usually develops in adults, is a disease characterized by red blood cells that develop abnormally. Once the abnormal cells are present in the bloodstream, naturally occurring proteins (called the complement system) designed to destroy bacteria and other infection-causing organisms break these cells down. This leads to abnormally darkened urine and, more importantly, causes anemia. Depending upon the severity of the disorder, patients with PNH may have pain, fatigue and debilitating weakness, the need for frequent blood transfusions, blood clots, and life-threatening or fatal strokes, heart attacks and intestinal disease.

Soliris does not cure PNH, but treats the breakdown of red blood cells, the most common characteristic of PNH. Soliris acts to block the complement system activity, including the destruction of PNH red blood cells.

FDA based its approval on the company's randomized, double-blind, placebo-controlled clinical study of 87 patients with PNH and a series of other clinical studies. The controlled study showed that over a 26-week period half of the participants receiving Soliris had stab
'"/>




Page: 1 2

Related medicine news :

1. FDA Approves Contraceptive Ring
2. FDA Approves New HIV Drug, Viread
3. FDA Approves Birth Control Skin Patch
4. FDA Approves New Arthritis Drug, Bextra
5. FDA Approves Elidel Cream for Eczema
6. FDA Approves New Anti-Clotting Drug
7. FDA Approves New surgery Treatment for Farsightedness
8. FDA Approves Anti-Cancer Cell Drug - Zevalin
9. FDA Approves Remodulin for Pulmonary Hypertension
10. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
11. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FDA Approves First its Kind Drug Treat Rare Blood Disorder

(Date:8/28/2014)... 28, 2014 In the healthcare industry, ... practices struggle with: How can the overall quality of ... study of the healthcare industry tackles this question, and ... employee job satisfaction and the quality of patient care. ... found in “ Organizational Factors related to Improving Quality ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 DoctorBase ... and mid-sized healthcare organizations, today announced that it has ... appointment company ZocDoc , to head their sales ... has created a sales management position. , “I’m passionate ... like DoctorBase that already has so much traction and ...
(Date:8/28/2014)... York (PRWEB) August 28, 2014 An unprecedented ... and neck issues, Cloud 9 Spine offers their resources online ... problems can quickly become a brick wall of discouragement as ... a professional opinion, Cloud 9 Spine offers a ... technology merged with human interaction that sets Cloud 9 Spine ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Top ... many web hosting companies and announces Bluehost, HostMonster ... recommended suppliers for the webmasters worldwide who want ... rates. , As the world’s most popular server-side ... and many other general-purpose programs. It is now ...
(Date:8/28/2014)... Now in its 4th year, Step for ... by two brain aneurysm survivors. The ongoing mission of Step ... to help increase early detection and to help support individuals ... We hope that you will be able to join this ... Annual Step for Hope Run/ Walk on Saturday, September 6, ...
Breaking Medicine News(10 mins):Health News:New Healthcare Study Explores Strategies for Improving Patient Care 2Health News:New Healthcare Study Explores Strategies for Improving Patient Care 3Health News:New Healthcare Study Explores Strategies for Improving Patient Care 4Health News:DoctorBase Hires Josh Angeles as Vice-President of Sales 2Health News:Making Waves on the East Coast, Cloud 9 Spine is Helping Patients Find Appointments With Local Spine Doctors 2Health News:Step for Hope and Raise Brain Aneurysm Awareness 2
... arise sporadically, rather than through inheritance of certain genes, ... allow environmentally triggered mutations to accumulate, according to researchers ... Hospital of UPMC and the University of Pittsburgh Cancer ... online edition of the Proceedings of the National ...
... the emergence of an epidemic of obesity and type 2 ... that may affect the risk of metabolic diseases is especially ... tend to have about 30% lower risk of developing late ... to be at lower risk of developing metabolic syndrome ...
... Reporter , MONDAY, Nov. 29 (HealthDay News) -- The prescription ... study suggests. But one expert was quick to note ... the pain of arthritis, has been linked in some studies ... So it isn,t yet clear that Celebrex (celecoxib) is an ...
... , MONDAY, Nov. 29 (HealthDay News) -- Smoking boosts the ... and those with a genetic risk factor for rheumatoid arthritis ... a new study has found. Researchers evaluated 605 black ... found that those with the disease were slightly more likely ...
... The American College of Physicians (ACP) today is sending ... internists speaking in their own words ( ... Congress to avert the scheduled Medicare Sustainable Growth Rate ... the repeated cycle of cuts. The 3-minute and ...
... the Psychoimmunology Unit at Lund University is presenting these results ... group led by Dr Lena Brundin, which sees inflammation in ... is a new theory that challenges the prevalent view that ... serotonin and noradrenaline. "However, current serotonin-based medication cures far ...
Cached Medicine News:Health News:Sporadic breast cancers start with ineffective DNA repair systems, Pitt researchers find 2Health News:Moderate alcohol consumption lowers the risk of metabolic diseases 2Health News:Celebrex Shows Potential in Preventing Some Skin Cancers: Study 2Health News:Celebrex Shows Potential in Preventing Some Skin Cancers: Study 3Health News:Heavy Smoking May Double Rheumatoid Arthritis Risk in Blacks 2Health News:Internists issue heartfelt plea for Congress to help patients by stopping Medicare SGR cuts 2Health News:Internists issue heartfelt plea for Congress to help patients by stopping Medicare SGR cuts 3Health News:Biological changes in suicidal patients 2
(Date:8/28/2014)... FRANKFURT AM MAIN, Germany , ... Risk App from Merz Pharmaceuticals is available free of charge ... risk for getting dementia within the next two decades. Using ... physicians discuss preventive measures with patients at risk. ... and Incidence of DEmentia) has been developed in collaboration with ...
(Date:8/27/2014)... China, Aug. 28, 2014 China Nepstar ... or the "Company"), a leading retail drugstore chain ... operated stores, today announced its unaudited financial results ... Financial HighlightsFor the quarter ended June 30, 2014: ... million (US$110.7 million) compared to RMB638.8 million in the ...
(Date:8/27/2014)... VANCOUVER, British Columbia and MENLO ... DelMar Pharmaceuticals, Inc. , (OTCQB: DMPI), developer of ... presenting company at the 16th Annual Rodman & Renshaw ... & Co., LLC. The presentation will take place Tuesday, September ... Salon (4th floor) at the New York Palace Hotel ...
Breaking Medicine Technology:CAIDE Looks into the Future: New App from Merz Pharmaceuticals Assesses the Risk of Getting Dementia Within the Next 20 Years 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 11DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4
... (Nasdaq: PRGO ; TASE) today announced that it ... foam brought by Stiefel Research Australia Pty. Ltd., a GSK ... in the U. S., a generic version of Men,s Rogaine® ... Rogaine® (Minoxidil) Foam is used to regrow ...
... Informex , the leading meeting place for buyers ... applications, today announced details of its second Latin American Green ... The event will be held in September 2011, with further ... 2011 event follows the success of the inaugural Informex Latin ...
Cached Medicine Technology:Perrigo Announces Settlement of Rogaine® Foam Patent Litigation 2Second Annual Latin America 'Green Exchange Conference' Hosted by Informex Focuses on a Sustainable Future for Chemistry 2Second Annual Latin America 'Green Exchange Conference' Hosted by Informex Focuses on a Sustainable Future for Chemistry 3
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
85 right angled suture passer....
The Mini-Revo suture anchor is designed primarily for arthroscopic and open Bankart shoulder repair. Additional applications include other shoulder repair procedures, as well as use in small joints....
... Labral Anchor is an L-PLA anchor ... soft tissue reattachment to bone. The ... bony contour of the glenoid, optimizing ... Osteo Compression (ROC) design to provide ...
Medicine Products: